# Study of GL701 in Men With Systemic Lupus Erythematosus

> **NCT00037128** · PHASE3 · UNKNOWN · sponsor: **Genelabs Technologies** · enrollment: 40 (—)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

- **DRUG:** GL701

## Key facts

- **NCT ID:** NCT00037128
- **Lead sponsor:** Genelabs Technologies
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1998-03
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 40 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00037128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00037128, "Study of GL701 in Men With Systemic Lupus Erythematosus". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00037128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*